Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials

Editorial: Hepatocellular Carcinoma: From Basic Research to Clinical Trials

Bibliographic Details
Main Authors:	Xing-Xing He, Da-Wei Ye
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma epigenetic alteration targeted therapy diagnosis prognosis bioinformatic analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.905654/full

Similar Items

Development and Validation of Epigenetic Modification-Related Signals for the Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Maoqing Lu, et al.
Published: (2021-06-01)

Hepatocellular carcinoma subtypes based on metabolic pathways reveals potential therapeutic targets
by: Zehua He, et al.
Published: (2023-03-01)

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
by: Xueying Zhao, et al.
Published: (2022-10-01)

Epigenetics in hepatocellular carcinoma development and therapy: The tip of the icebergKey points
by: Maite G. Fernández-Barrena, et al.
Published: (2020-12-01)

Comprehensive Analysis of the Expression of Cell Adhesion Molecules Genes in Hepatocellular Carcinoma and their Prognosis, and Biological Significance
by: Jia Wang, et al.
Published: (2024-02-01)

Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma
by: Florin Graur, et al.
Published: (2022-05-01)

Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach
by: Eskezeia Yihunie Dessie, et al.
Published: (2021-02-01)

Editorial: Identification and characterization of molecular targets in hepatocellular carcinoma
by: Vinay Kumar, et al.
Published: (2023-06-01)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
by: Shanjia Ke, et al.
Published: (2022-11-01)

Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma
by: Zaixiong Ji, et al.
Published: (2021-05-01)

Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma
by: Wen-Jie Fan, et al.
Published: (2023-04-01)

Glia Maturation Factor Beta as a Novel Biomarker and Therapeutic Target for Hepatocellular Carcinoma
by: Wan Sun, et al.
Published: (2021-11-01)

Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
by: Tsuguru Hayashi, et al.
Published: (2020-10-01)

The prognostic value and clinical significance of mitophagy-related genes in hepatocellular carcinoma
by: Wei Xu, et al.
Published: (2022-08-01)

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
by: Qinjunjie Chen, et al.
Published: (2020-08-01)

Comprehensive Analysis of Prognostic Value and Immune Infiltration of Ficolin Family Members in Hepatocellular Carcinoma
by: Liang Sun, et al.
Published: (2022-07-01)

Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma
by: Zhipeng Zhu, et al.
Published: (2020-05-01)

Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma
by: Kunfu Dai, et al.
Published: (2022-05-01)

Integrated Proteomics and Bioinformatics to Identify Potential Prognostic Biomarkers in Hepatocellular Carcinoma
by: Zhang Q, et al.
Published: (2021-03-01)

Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy
by: Yusuke Sugama, et al.
Published: (2021-12-01)

Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma
by: Shanshan Chen, et al.
Published: (2022-03-01)

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study
by: Laizhu Zhang, et al.
Published: (2023-11-01)

MicroRNAs as Diagnostic Tools in Hepatocellular Carcinoma
by: Jessica Evangelista, et al.
Published: (2021-11-01)

Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians
by: Kaige Deng, et al.
Published: (2023-10-01)

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth
by: Yan Yan, et al.
Published: (2022-12-01)

Clinical significance of small nuclear ribonucleoprotein U1 subunit 70 in patients with hepatocellular carcinoma
by: Dong Jiang, et al.
Published: (2024-03-01)

Identification and functional analysis of lactic acid metabolism-related differentially expressed genes in hepatocellular carcinoma
by: Haiyan Li, et al.
Published: (2024-04-01)

A genomic enhancer signature associates with hepatocellular carcinoma prognosis
by: Ah-Jung Jeon, et al.
Published: (2023-06-01)

Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma
by: Leva Gorji, et al.
Published: (2023-08-01)

Pre-treatment alphafeto protein in hepatocellular carcinoma with non-viral aetiology – a prospective study
by: Siriwardana Rohan Chaminda, et al.
Published: (2017-12-01)

SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
by: Wonbeak Yoo, et al.
Published: (2023-11-01)

Gene-based cancer-testis antigens as prognostic indicators in hepatocellular carcinoma
by: Yingyu Xu, et al.
Published: (2023-03-01)

Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma
by: Wen-Jing Su, et al.
Published: (2021-01-01)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
by: Shuqi Xie, et al.
Published: (2023-05-01)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
by: Manali Dimri, et al.
Published: (2020-02-01)

The Mechanism and Clinical Significance of Circular RNAs in Hepatocellular Carcinoma
by: Ziyue Huang, et al.
Published: (2021-09-01)

Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma
by: Yixian He, et al.
Published: (2023-04-01)

TMEM147 is a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
by: Wen-Jie Fan, et al.
Published: (2023-06-01)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
by: Xiaoyi Hu, et al.
Published: (2020-11-01)

Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma
by: Chen Li, et al.
Published: (2015-05-01)